Teaneck, New Jersey Clinical Trials

AutoRun122497

AutomationRun122497

AutoSite122497

 (7.7 away) Contact site

AutoRun122492  

AutomationRun122492

AutoSite122492

 (7.7 away)

AutoRun129  

AutomationRun129

AutoSite129

 (7.7 away)

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).

Hackensack University Medical Center

 (1.9 away) Contact site

A Dietary Study for People With Multiple Myeloma  

The purpose of the study is to find out whether a dietary intervention can affect treatment response and/or quality of life for people with newly diagnosed multiple myeloma receiving standard induction chemotherapy with daratumumab (or isatuximab), lenalidomide, bortezomib, and dexamethasone (DRVd). The researchers will measure quality of life by having …

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

 (9.1 away)

new widget 1

new widget

 (9.5 away) Contact site

TrialXAutomationRun800

TrialXAutomationRun

TrialXAutoSite800

 (7.7 away) Contact site

TrialXAutomationRun800

TrialXAutomationRun

TrialXAutoSite855

 (7.7 away) Contact site

TrialXAutomationRun866  

TrialXAutomationRun

TrialXAutoSite866

 (7.7 away)

TrialXAutomationRun700  

TrialXAutomationRun

TrialXAutoSite700

 (7.7 away)